P2Y receptors activated by diadenosine polyphosphates reestablish Ca2+ transients in achondroplasic chondrocytes

Bone

Volumn 42, Issue 3, 2008, Pages 516-523

  Guzmán Aránguez, Ana ^a   Irazu, Marta ^a   Yayon, Avner ^b   Pintor, Jesús ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b ProChon Biotech Ltd   (Israel)

Author keywords

Achondroplasia; Calcium; Chondrocytes; FGFR3; P2Y receptors

Indexed keywords

CALCIUM ION; DIADENOSINE POLYPHOSPHATE; DIADENOSINE TRIPHOSPHATE; DINUCLEOTIDE; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTOR RECEPTOR 3; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y11 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR;

ACHONDROPLASIA; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CARTILAGE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DWARFISM; FLUORESCENCE; GENE MUTATION; IMMUNOCYTOCHEMISTRY; IMMUNOLOCALIZATION; MOUSE; NONHUMAN; WESTERN BLOTTING;

ACHONDROPLASIA; ANIMALS; CALCIUM; CALCIUM SIGNALING; CHONDROCYTES; DINUCLEOSIDE PHOSPHATES; HUMANS; MICE; MICE, TRANSGENIC; PROTEIN ISOFORMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, PURINERGIC P2;

EID: 39149086079     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.10.023     Document Type: Article

References (24)

1. Kobayashi T., and Kronenberg H. Minireview: transcriptional regulation in development of bone. Endocrinology 146 (2005) 1012-1017
2. Provot S., and Schipani E. Molecular mechanisms of endochondral bone development. Biochem Biophys Res Commun 328 (2005) 658-665
3. L'Hote C.G., and Knowles M.A. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 304 (2005) 417-431
4. Nguyen H.B., Estacion M., and Gargus J.J. Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts. Hum Mol Genet 6 (1997) 681-688
5. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58 (2006) 58-86
6. Fischer B., Therapeutic applications of ATP-(P2)-receptors agonists and antagonists. Exp. Opin. Ther. Patents 1999;9:385-399.
7. Boeynaems J.M., Communi D., Gonzalez N.S., and Robaye B. Overview of the P2 receptors. Semin Thromb Hemost 31 (2005) 139-149
8. North R.A. Molecular physiology of P2X receptors. Physiol Rev 82 (2002) 1013-1067
9. Caswell A.M., Leong W.S., and Russell R.G. Evidence for the presence of P2-purinoceptors at the surface of human articular chondrocytes in monolayer culture. Biochim Biophys Acta 1074 (1991) 151-158
10. Daub H., Weiss F.U., Wallasch C., and Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379 (1996) 557-560
11. Segev O., Chumakov I., Nevo Z., Givol D., Madar-Shapiro L., Sheinin Y., et al. Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum Mol Genet 9 (2000) 249-258
12. Carbone E., and Swandulla D. Neuronal calcium channels: kinetics, blockade and modulation. Prog Biophys Mol Biol 54 (1989) 31-58
13. 2+-dependent regulation of presynaptic stimulus-secretion coupling. J Neurochem 53 (1989) 1188-1194
14. Hoebertz A., Townsend-Nicholson A., Glass R., Burnstock G., and Arnett T.R. Expression of P2 receptors in bone and cultured bone cells. Bone 27 (2000) 503-510
15. Koolpe M., Pearson D., and Benton H.P. Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release. Arthritis Rheum 42 (1999) 258-267
16. Ekstein J., Nasatzky E., Boyan B.D., Ornoy A., and Schwartz Z. Growth-plate chondrocytes respond to 17beta-estradiol with sex-specific increases in IP3 and intracellular calcium ion signalling via a capacitative entry mechanism. Steroids 70 (2005) 775-786
17. Pintor J., and Miras-Portugal M.T. Receptors for diadenosine polyphosphates P2D, P2YApnA, P4 and dinucleotide receptors: are there too many?. Trends Pharmacol Sci 21 (2000) 135
18. Lazarowski E.R., Watt W.C., Stutts M.J., Boucher R.C., and Harden T.K. Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br J Pharmacol 116 (1995) 1619-1627
19. Patel K., Barnes A., Camacho J., Paterson C., Boughtflower R., Cousens D., et al. Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells. Eur J Pharmacol 430 (2001) 203-210
20. Abe M., and Naski M.C. Regulation of sprouty expression by PLCgamma and calcium-dependent signals. Biochem Biophys Res Commun 323 (2004) 1040-1047
21. 2+ flux but not mitogenesis. Nature 358 (1992) 678-681
22. Cross M.J., Lu L., Magnusson P., Nyqvist D., Holmqvist K., Welsh M., et al. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Mol Biol Cell 13 (2002) 2881-2893
23. Hart K.C., Robertson S.C., and Donoghue D.J. Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation. Mol Biol Cell 12 (2001) 931-942
24. Zuscik M.J., D'Souza M., Ionescu A.M., Gunter K.K., Gunter T.E., O'Keefe R.J., et al. Growth plate chondrocyte maturation is regulated by basal intracellular calcium. Exp Cell Res 276 (2002) 310-319